Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck

International Journal of Molecular Medicine

Volumn 19, Issue 3, 2007, Pages 421-428

  McLaughlin, Patricia J ^a   Verderame, Michael F ^a   Hankins, Jody L ^a   Zagon, Ian S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

DNA synthesis; Opioid growth factor receptor; Opioids; Squamous cell carcinoma of the head and neck; Transfection

Indexed keywords

ANTIBODY; BROXURIDINE; DNA; METENKEPHALIN; METHIONINE ENKEPHALIN RECEPTOR; METHIONINE-ENKEPHALIN RECEPTOR; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

AGED; ARTICLE; BIOSYNTHESIS; CELL CLONE; CELL COUNT; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; GENETICS; HEAD AND NECK TUMOR; HUMAN; IMMUNOLOGY; KINETICS; MALE; METABOLISM; PATHOLOGY; PROTEIN BINDING; PROTEIN TRANSPORT; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

AGED; ANTIBODIES; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; CELL COUNT; CELL LINE, TUMOR; CELL PROLIFERATION; CLONE CELLS; DNA, NEOPLASM; DOWN-REGULATION; ENKEPHALIN, METHIONINE; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMANS; KINETICS; MALE; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, OPIOID;

EID: 33947521078     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.3.421     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
2. Parkin DM, Pisani P and Ferlay J: Global cancer statistics. CA Cancer J Clin 49: 33-64, 1999.
3. Carew JF and Shah JP: Advances in multimodality therapy for laryngeal cancer. CA Cancer J Clin 48: 211-228, 1998.
4. 5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma. Laryngoscope 107: 335-339, 1997.
5. McLaughlin PJ, Levin RJ and Zagon IS: Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor. Int J Oncol 14: 991-998, 1999.
6. McLaughlin PJ, Levin RJ and Zagon IS: The opioid growth factor receptor in human head and neck squamous cell carcinoma. Int J Mol Med 5: 191-196, 2000.
7. Zagon IS, Roesener CD, Verderame MF, Ohlsson-Wilhelm BM, Levin RJ and McLaughlin PJ: Opioid growth factor regulates the cell cycle of human neoplasias. Int J Oncol 17: 1053-1061, 2000.
8. Zagon IS, Verderame MF, Allen SS and McLaughlin PJ: Cloning, sequencing, chromosomal location, and function of a cDNA encoding the opioid growth factor receptor (OGFr) in humans. Brain Res 856: 75-83, 2000.
9. Zagon IS, Verderame MF and McLaughlin PJ: The biology of the opioid growth factor receptor (OGFr). Brain Res Rev 38: 351-376, 2002.
10. McLaughlin PJ, Stack BC, Levin RJ, Fedok F and Zagon IS: Defects in the OGF receptor (OGFr) in human squamous cell carcinoma of the head and neck. Cancer 97: 1701-1710, 2003.
11. Zagon IS and McLaughlin PJ: Opioids and the apoptotic pathway in human cancer cells. Neuropeptides 37: 79-88, 2003.
12. McLaughlin PJ, Levin RJ and Zagon IS: Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice. Cancer Lett 199: 209-217, 2003.
13. Zagon IS and McLaughlin PJ: Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells. Int J Oncol 24: 1443-1148, 2004.
14. McLaughlin PJ, Stack BC, Braine KM, Ruda JD and Zagon IS: Opioid growth factor inhibition of a human squamous cell carcinoma of the head and neck in nude mice: Dependency on the route of administration. Int J Oncol 24: 227-232, 2004.
15. Jaglowski JR, Zagon IS, Stack BC, Verderame MF, Leure-duPree AE, Manning JD and McLaughlin PJ: Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 56: 97-104, 2005.
16. McLaughlin PJ, Jaglowski JR, Verderame MF, Stack BC, Leure-duPree AE and Zagon IS: Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor. Int J Oncol 26: 809-816, 2005.
17. Zagon IS and McLaughlin PJ: Opioid growth factor, opioids, and differentiation of human cancer cells. Neuropeptides 39: 495-505, 2005.
18. Cheng F, Zagon IS, Verderame MF and McLaughlin PJ: OGF-OGFr axis and its inhibitory actions on cell cycle progression of head and neck cancer cell line SCC1. Mol Biol Cell 16: 77, 2005.
19. McLaughlin PJ and Zagon IS: Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor. Int J Oncol 28: 1577-1583, 2006.
20. Zagon IS, Wu Y and McLaughlin PJ: Opioid growth factor inhibits DNA synthesis in mouse tongue epithelium in a circadian rhythm-dependent manner. Am J Physiol 267: R645-R652, 1994.
21. 5]-enkephalin, and the ζ (zeta) opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis. J Invest Dermatol 106: 490-497, 1996.
22. Zagon IS, Ruth TB, Leure-duPree AE, Sassani JW and McLaughlin PJ: Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea. Brain Res 967: 37-47, 2003.
23. Zagon IS, Ruth TB and McLaughlin PJ: Nucleocytoplasmic distribution of opioid growth factor (OGF) and its receptor (OGFr) in tongue epithelium. Anat Rec 282A: 24-37, 2005.
24. Krause CJ, Carey TE, Ott RW, Hurbis C, McClatchey KD and Regezi JA: Human squamous cell carcinoma. Arch Otolaryngol 107: 703-710, 1981.
25. 5]-enkephalin. Brain Res 849: 147-154, 1999.
26. Zagon IS, Sassani JW, Verderame MF and McLaughlin PJ: Particle-mediated gene transfer of OGFr cDNA regulates cell proliferation of the corneal epithelium. Cornea 24: 614-619, 2005.
27. Zagon IS, Sassani JW, Malefyt KJ and McLaughlin PJ: Particle-mediated gene transfer of OGFr cDNA regulates corneal repair. Arch Ophthalmol 124: 1620-1624, 2006.